ARCHIVES

Guest Editorial : Why I Don’t Want to Pay for Your Horoscope: Reflections on FDA Warning to 23 and Me

This article is from The Cancer Letter archive.

Vol. 39 No. 46 | December 13, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Approved More Than 50 New Indications For Cancer In 32 Months, Analysis Finds

February 19, 2010

In Phase II Study, NKTR-102 Shows Objective Response

January 28, 2011

California approves $3 billion program for stem-cell research.

November 5, 2004

CMS To Recognize NCCN’s Drug Compendium.

June 6, 2008

In Brief: NIH Conference To Explore Conflict Of Interest Issues; Five NCUI Executive Win PHS Awards

May 26, 1989

FDA News: Clinton Nominates Jane Henney For FDA Commissioner

June 26, 1998